DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS
Want to know more about Dexur's Capabilities? Get In Touch
Jan 2013 to Dec 2017   |   Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | |
DEMOGRAPHIC DETAILS OF DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
Race |
Total Hospitalization Volume - Jan 2017 to Dec 2017 |
% of DRG Volume |
White |
107 |
77.54 |
Black |
21 |
15.22 |
Hispanic |
NA |
NA |
|
|
|
|
|
|
Age Group ( Years ) |
Total Hospitalization Volume - Jan 2017 to Dec 2017 |
% of DRG Volume |
Less than 65 |
43 |
31.16 |
65 to 69 |
35 |
25.36 |
70 to 74 |
22 |
15.94 |
|
|
|
|
|
|
|
|
|
TOP ICD DIAGNOSIS CODES FOR DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP ICD PROCEDURE CODES FOR DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP HOSPITALS ASSOCIATED WITH DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
DRG 712: TESTES PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | |
Category |
Sub Category |
DRG Group |
ICD Codes |
ICD Description |
National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - All) Jan 2017 to Dec 2017 |
National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Yes) Jan 2017 to Dec 2017 |
National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Not Y) Jan 2017 to Dec 2017 |
Total Discharges After Exclusion |
Avg. LOS |
GMLOS |
All Cause Readmission Rate (%) |
Unplanned Readmission Rate (%) |
Total Medicare Payments |
Payment per Day |
Payment per Discharge |
Total Medicare Charges |
Avg. Charges |
Mortality Rate (%) |
SNF Discharge Rate (%) |
Home Discharge Rate (%) |
Urology |
Testes Procedures |
Testes Procedures |
I10 |
Essential (primary) hypertension |
416 |
64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
N433 |
Hydrocele, unspecified |
522 |
41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
E785 |
Hyperlipidemia, unspecified |
204 |
40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
Z87891 |
Personal history of nicotine dependence |
161 |
28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
I2510 |
Atherosclerotic heart disease of native coronary artery without angina pectoris |
106 |
25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
E119 |
Type 2 diabetes mellitus without complications |
157 |
24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
K219 |
Gastro-esophageal reflux disease without esophagitis |
144 |
23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
N453 |
Epididymo-orchitis |
140 |
23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
N492 |
Inflammatory disorders of scrotum |
136 |
21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
F17210 |
Nicotine dependence, cigarettes, uncomplicated |
301 |
20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|